Kevin Michael Mullins - 03 Jul 2023 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Chief Development Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
03 Jul 2023
Transactions value $
-$1,799,400
Form type
4
Filing time
06 Jul 2023, 16:30:37 UTC
Previous filing
27 Jun 2023
Next filing
07 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Sale -$491K -54.6K -1.02% $9.00 5.32M 03 Jul 2023 Direct F1, F2
transaction LFST Common Stock Sale -$1.31M -150K -2.82% $8.72 5.17M 05 Jul 2023 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.91 to $9.13 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.63 to $8.96 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.